109 Division OF Hem/Onc: Oncology Board Review Conference " " (120822)

Dallas, TX US
December 8, 2022
Course summary
Available credit: 
  • 1.00 AMA
  • 1.00 Attendance
Course opens: 
12/08/2022
Course expires: 
12/08/2022
Event starts: 
12/08/2022 - 7:30am CST
Event ends: 
12/08/2022 - 8:30am CST
Cost:
$0.00
Part of: 
109 DIVISION OF HEM/ONC: ONCOLOGY BOARD REVIEW CONFERENCE 2022
Add to calendar: 
UT Southwestern Medical Center
5323 Harry Hines Blvd.
Dallas, TX 75390
United States
Course Director(s)

Amy Jones, M.D.

has no relevant financial relationships to disclose at this time.
Peer reviewer(s)

Amy Jones, M.D.

has no relevant financial relationships to disclose at this time.
Speaker(s)

Tian Zhang, MD, MHS

has a financial relationship (Professional Services) with Merck, Exelixis, Sanofi-Aventis, Janssen, AstraZeneca, Pfizer, Amgen, BMS, Pharmacyclics, SeaGen, Calithera, Dendreon, QED Therapeutics, Eisai, Aveo Pharmaceuticals, Bayer, Eli Lilly;.
has a financial relationship (Professional Services) with Pfizer, MJH Associates, Vaniam, Aptitude Health, PeerView, Clinical Care Options;.
has a financial relationship (Grant Or Contract) with Acerta, Novartis, Merrimack, Abbvie/StemCentrx, Merck, Regeron, Mirati Therapeutics, Janssen, AstraZeneca, Pfizer, OmniSeq, Personal Genome Diagnostics, Astellas;.

Available Credit

  • 1.00 AMA
  • 1.00 Attendance

Price

Cost:
$0.00
Please login or create an account to take this course.